3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals

Dolores R. Serrano, Aytug Kara, I. Yuste, Francis C Luciano, Baris Ongoren, Bryan J Anaya, Gracia Molina, Laura Diez, Bianca I Ramirez, Irving O Ramirez, Sergio Sánchez- Guirales, Raquel Fernandez-García, Liliana Bautista, Helga K. Ruiz, Katerina Lalatsa

Research output: Contribution to journalReview articlepeer-review

91 Citations (Scopus)
34 Downloads (Pure)

Abstract

3D printing technologies enable medicine customization adapted to patients' needs. There are several 3D printing techniques available, but majority of dosage forms and medical devices are printed using nozzle-based extrusion, laser-writing systems, and powder binder jetting. 3D printing has been demonstrated for a broad range of applications in development and targeting solid, semi-solid and locally applied or implanted medicines. 3D printed solid dosage forms allow the combination of one or more drugs within the same solid dosage form to improve patient compliance, facilitate deglutition, tailor the release profile, or fabricate new medicines for which no dosage form is available. Sustained release 3D-printed implants, stents and medical devices have been used mainly for joint replacement therapies, medical prostheses, and cardiovascular applications. Locally applied medicines such as wound dressing, microneedles, and medicated contact lenses have also been manufactured using 3D printing techniques. The challenge is to select the 3D printing tech-nique most suitable for each application and the type of pharmaceutical ink that should be devel-oped that possesses the required physicochemical and biological performance. The integration of biopharmaceuticals and nanotechnology-based drugs along with 3D printing ("Nanoprinting") brings printed personalized nanomedicines within the most innovative perspectives for the coming years. Continuous manufacturing through the use of 3D-printed microfluidic chips facilitates their translation into clinical practice.
Original languageEnglish
Article number313
Number of pages28
JournalPharmaceutics
Volume15
Issue number2
DOIs
Publication statusPublished - 17 Jan 2023

Funding

This research was funded by Universidad Complutense de Madrid (910939) Formulacion y biodisponibilidad de nuevos medicamentos. This study/project has been funded by a research grant (year 2021, ID: 16306) from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to Dolores Serrano. This study has been also funded by the Ministry of Science and Innovation (award PID2021-126310OA-I00 to Dolores Serrano).

Keywords

  • personalized medicines
  • 3D printing
  • FDM
  • fuse deposition modelling
  • SLA
  • stereolithography
  • PAM
  • pressure-assisted microsyringes
  • SLS
  • selective laser sintering
  • bioprinting
  • nanomedicines
  • nanoparticle
  • peptide hydrogel
  • microfluidic chip

Fingerprint

Dive into the research topics of '3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals'. Together they form a unique fingerprint.

Cite this